Lucien Goffart

Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France.

Opsens, Inc. engages in the development, manufacture, supply, and installation of fiber optic systems for measuring pressure and temperature. It operates through the Medical and Industrial business segments. The Medical segment focuses on the physiological measurement in interventional cardiology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for critical applications such as the monitoring of oil wells and demanding industrial applications. The company was founded in 2003 and is headquartered in Quebec, Canada.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Robocath SAS develops robotics medical devices for cardiac pathologies. It allows doctors to perform coronary angioplasties by controlling the catheters whilst seating behind a control station that is protected from X-rays. The company was founded by Philippe Bencteux in 2009 and is headquartered in Rouen, France.